Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10897360rdf:typepubmed:Citationlld:pubmed
pubmed-article:10897360lifeskim:mentionsumls-concept:C0023290lld:lifeskim
pubmed-article:10897360lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:10897360lifeskim:mentionsumls-concept:C0011900lld:lifeskim
pubmed-article:10897360lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:10897360lifeskim:mentionsumls-concept:C0014441lld:lifeskim
pubmed-article:10897360pubmed:issue2lld:pubmed
pubmed-article:10897360pubmed:dateCreated2000-8-17lld:pubmed
pubmed-article:10897360pubmed:abstractTextA purified 200-kDa antigenic fraction from Leishmania donovani axenic amastigotes was evaluated by ELISA for the detection of antibody response in visceral leishmaniasis (VL) patients, post kala-azar dermal leishmaniasis (PKDL) patients and controls, for the diagnosis of visceral leishmaniasis. A positive antibody response to the 200-kDa amastigote fraction and to Leishmania amastigote soluble antigen (LASA) was found in 29 (96.6%) and 30 ((100%) confirmed VL patients, respectively, by the use of ELISA. However, only 1 (10%) out of 10 PKDL patients had detectable antibody response to 200-kDa fraction while all the 10 (100%) PKDL patients exhibited an immune response to LASA. Therefore, use of the 200-kDa antigenic fraction for the detection of antibody response in an ELISA follow-up (post treatment) of VL patients may have prognostic significance, and it may also be useful for differentiating active VL and PKDL.lld:pubmed
pubmed-article:10897360pubmed:languageenglld:pubmed
pubmed-article:10897360pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10897360pubmed:citationSubsetIMlld:pubmed
pubmed-article:10897360pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10897360pubmed:statusMEDLINElld:pubmed
pubmed-article:10897360pubmed:issn0035-9203lld:pubmed
pubmed-article:10897360pubmed:authorpubmed-author:KaurSSlld:pubmed
pubmed-article:10897360pubmed:authorpubmed-author:MahajanR CRClld:pubmed
pubmed-article:10897360pubmed:authorpubmed-author:GangulyN KNKlld:pubmed
pubmed-article:10897360pubmed:authorpubmed-author:KaunRRlld:pubmed
pubmed-article:10897360pubmed:authorpubmed-author:MallaNNlld:pubmed
pubmed-article:10897360pubmed:issnTypePrintlld:pubmed
pubmed-article:10897360pubmed:volume94lld:pubmed
pubmed-article:10897360pubmed:ownerNLMlld:pubmed
pubmed-article:10897360pubmed:authorsCompleteYlld:pubmed
pubmed-article:10897360pubmed:pagination173-5lld:pubmed
pubmed-article:10897360pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10897360pubmed:meshHeadingpubmed-meshheading:10897360...lld:pubmed
pubmed-article:10897360pubmed:meshHeadingpubmed-meshheading:10897360...lld:pubmed
pubmed-article:10897360pubmed:meshHeadingpubmed-meshheading:10897360...lld:pubmed
pubmed-article:10897360pubmed:meshHeadingpubmed-meshheading:10897360...lld:pubmed
pubmed-article:10897360pubmed:meshHeadingpubmed-meshheading:10897360...lld:pubmed
pubmed-article:10897360pubmed:meshHeadingpubmed-meshheading:10897360...lld:pubmed
pubmed-article:10897360pubmed:meshHeadingpubmed-meshheading:10897360...lld:pubmed
pubmed-article:10897360pubmed:articleTitleEvaluation of a 200-kDa amastigote-specific antigen of L. donovani by enzyme-linked immunosorbent assay (ELISA) for the diagnosis of visceral leishmaniasis.lld:pubmed
pubmed-article:10897360pubmed:affiliationDepartment of Experimental Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.lld:pubmed
pubmed-article:10897360pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10897360lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10897360lld:pubmed